Strengthening Capacity through Improved Management and Coordination of Laboratory, Surveillance, Epidemiology Public Health Evaluations and Training in Uganda under PEPFAR | CDC RFA GH12 121205CONT17

Opportunity Information: Apply for CDC RFA GH12 121205CONT17

The grant opportunity titled "Strengthening Capacity through Improved Management and Coordination of Laboratory, Surveillance, Epidemiology Public Health Evaluations and Training in Uganda under PEPFAR" is a U.S. government public health funding action administered by the Centers for Disease Control and Prevention (CDC) within the Department of Health and Human Services. It is designed to support work in Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR), with the overall focus on strengthening national and program capacity in several core public health functions that underpin effective HIV and broader health responses. The emphasis signaled by the title is not simply on delivering services, but on improving how key systems are managed and coordinated so that laboratory services, disease surveillance, epidemiology practice, public health evaluations, and workforce training operate in a more aligned, consistent, and effective way.

This opportunity is issued as a Cooperative Agreement, which typically means CDC expects to have substantial involvement in the work beyond standard grants management. In practical terms, Cooperative Agreements often involve ongoing technical collaboration, joint planning, and close coordination on implementation and reporting. The funding instrument and the wording of the opportunity suggest that CDC intends the recipient to carry out capacity-building and coordination activities in partnership with national stakeholders, while CDC provides technical direction, oversight, and alignment with PEPFAR priorities and U.S. government reporting requirements.

The opportunity category is listed as Continuation, and the funding opportunity number is CDC RFA GH12 121205CONT17. A continuation action generally indicates this is not a brand-new competitive announcement for a wide field of new applicants, but a follow-on or extension tied to an existing programmatic relationship or previously funded work. That context is consistent with the very limited number of anticipated awards, which is listed as one expected award. Together, "continuation" status and a single expected award usually mean the funding is intended to maintain momentum, preserve program continuity, and deepen prior investments rather than start an entirely new initiative with multiple implementing partners.

From a programmatic standpoint, the content areas named in the title point to a comprehensive systems approach. "Laboratory" typically covers strengthening the infrastructure and management of diagnostic networks, quality management systems, specimen referral systems, testing standards, and coordination across tiers of the health system. "Surveillance" and "epidemiology" point to improving the collection, analysis, interpretation, and use of data for decision-making, including outbreak detection, monitoring disease trends, and tracking program performance. "Public health evaluations" suggests a focus on assessing whether interventions are working as intended, improving program quality, and generating evidence for adjustments in strategy. "Training" implies workforce development, mentoring, and institutional strengthening so that improvements are durable and locally owned. The repeated emphasis on "improved management and coordination" signals that the work is intended to tie these components together so they function as an integrated system rather than siloed activities.

Administratively, the funding activity category is Health, and the CFDA number is 93.067, which corresponds to a CDC global health assistance program area. The awarding agency is listed as the Department of Health and Human Services, Centers for Disease Control and Prevention - CGH, indicating involvement from CDC's Center for Global Health. The creation date is October 6, 2016, and the original closing date is December 8, 2016, which establishes the timeframe in which applications or continuation materials were due under this announcement.

On funding specifics, the award ceiling is listed as 0. In federal opportunity listings, a ceiling of 0 can mean the amount is not publicly specified in the synopsis, may be determined through continuation increments, may depend on availability of funds, or may be provided elsewhere in the full announcement package. It should not be read as implying no funding will be provided; rather, it indicates that the public summary does not state a maximum award level.

Eligibility is described as "Others" with a note to consult additional eligibility text. That phrasing is common in listings where eligibility is restricted or defined in a more specific way than broad categories like nonprofits, universities, or governments. In continuation opportunities, eligibility is often effectively limited to the current recipient or a narrowly defined set of entities. The synopsis does not provide the detailed eligibility language, so the precise eligible applicant type cannot be confirmed from the excerpt alone.

In short, this CDC/PEPFAR opportunity is a continuation Cooperative Agreement aimed at reinforcing Uganda's public health infrastructure by improving how laboratory systems, surveillance and epidemiology functions, evaluation activities, and training efforts are managed and coordinated. It is positioned as a targeted, likely single-recipient action intended to sustain and strengthen an existing program rather than launch a broad new competition, with CDC playing an active collaborative role typical of Cooperative Agreements.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Strengthening Capacity through Improved Management and Coordination of Laboratory, Surveillance, Epidemiology Public Health Evaluations and Training in Uganda under PEPFAR" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Oct 06, 2016.
• Applicants must submit their applications by Dec 08, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH12 121205CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: